• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血小板参数、血脂水平和血管造影特征的预测模型,预测冠心病患者药物洗脱支架置入后支架内再狭窄。

A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.

机构信息

State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, No. 137, Liyushan Road, Urumqi, China.

出版信息

Lipids Health Dis. 2021 Sep 29;20(1):118. doi: 10.1186/s12944-021-01553-2.

DOI:10.1186/s12944-021-01553-2
PMID:34587955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8480001/
Abstract

BACKGROUND

The present study was aimed to establish a prediction model for in-stent restenosis (ISR) in subjects who had undergone percutaneous coronary intervention (PCI) with drug-eluting stents (DESs).

MATERIALS AND METHODS

A retrospective cohort study was conducted. From September 2010 to September 2013, we included 968 subjects who had received coronary follow-up angiography after primary PCI. The logistic regression analysis, receiver operator characteristic (ROC) analysis, nomogram analysis, Hosmer-Lemeshow χ statistic, and calibration curve were applied to build and evaluate the prediction model.

RESULTS

Fifty-six patients (5.79%) occurred ISR. The platelet distribution width (PDW), total cholesterol (TC), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and lesion vessels had significant differences between ISR and non-ISR groups (all P < 0.05). And these variables were independently associated with ISR (all P < 0.05). Furthermore, they were identified as predictors (all AUC > 0.5 and P < 0.05) to establish a prediction model. The prediction model showed a good value of area under curve (AUC) (95%CI): 0.72 (0.64-0.80), and its optimized cut-off was 6.39 with 71% sensitivity and 65% specificity to predict ISR.

CONCLUSION

The incidence of ISR is 5.79% in CAD patients with DES implantation in the Xinjiang population, China. The prediction model based on PDW, SBP, TC, LDL-C, and lesion vessels was an effective model to predict ISR in CAD patients with DESs implantation.

摘要

背景

本研究旨在建立经皮冠状动脉介入治疗(PCI)置入药物洗脱支架(DES)后发生支架内再狭窄(ISR)的预测模型。

材料与方法

采用回顾性队列研究。纳入 2010 年 9 月至 2013 年 9 月于我院接受初次 PCI 后进行冠状动脉随访造影的 968 例患者。采用逻辑回归分析、受试者工作特征(ROC)曲线分析、列线图分析、Hosmer-Lemeshow χ 检验和校准曲线构建并评估预测模型。

结果

56 例(5.79%)患者发生 ISR。ISR 组与非 ISR 组血小板分布宽度(PDW)、总胆固醇(TC)、收缩压(SBP)、低密度脂蛋白胆固醇(LDL-C)及病变血管数比较,差异均有统计学意义(均 P<0.05)。上述变量均与 ISR 独立相关(均 P<0.05)。进一步将其确定为预测因素(均 AUC>0.5,P<0.05)建立预测模型。该预测模型的曲线下面积(AUC)为 0.72(95%CI:0.64~0.80),其最佳截断值为 6.39,预测 ISR 的灵敏度为 71%,特异度为 65%。

结论

在中国新疆地区 CAD 患者 DES 置入后 ISR 的发生率为 5.79%。基于 PDW、SBP、TC、LDL-C 和病变血管建立的预测模型是预测 CAD 患者 DES 置入后 ISR 的有效模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fc/8480001/12488f775b7e/12944_2021_1553_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fc/8480001/5653be84cb2d/12944_2021_1553_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fc/8480001/12488f775b7e/12944_2021_1553_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fc/8480001/5653be84cb2d/12944_2021_1553_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fc/8480001/12488f775b7e/12944_2021_1553_Fig2_HTML.jpg

相似文献

1
A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.基于血小板参数、血脂水平和血管造影特征的预测模型,预测冠心病患者药物洗脱支架置入后支架内再狭窄。
Lipids Health Dis. 2021 Sep 29;20(1):118. doi: 10.1186/s12944-021-01553-2.
2
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.
3
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者支架内再狭窄风险预测列线图的建立与验证。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):435. doi: 10.1186/s12872-021-02255-4.
4
Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.入院时血小板分布宽度预测经皮冠状动脉介入治疗的冠心病合并 2 型糖尿病患者的支架内再狭窄。
Chin Med J (Engl). 2018 Apr 5;131(7):757-763. doi: 10.4103/0366-6999.228247.
5
Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.残余脂蛋白胆固醇与冠状动脉疾病药物洗脱支架置入术后支架内再狭窄独立相关。
Angiology. 2019 Oct;70(9):853-859. doi: 10.1177/0003319719854296. Epub 2019 Jun 5.
6
A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis.预测经皮冠状动脉介入治疗患者支架内再狭窄风险的列线图:基于人群的分析
Int J Gen Med. 2022 Mar 3;15:2451-2461. doi: 10.2147/IJGM.S357250. eCollection 2022.
7
The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.接受药物洗脱支架置入术的冠心病患者中纤维蛋白原与白蛋白比值与支架内再狭窄的关系。
Coron Artery Dis. 2020 Nov;31(7):586-589. doi: 10.1097/MCA.0000000000000890.
8
Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.血管内超声衍生的支架尺寸作为股浅动脉镍钛诺支架植入术后血管造影再狭窄的预测指标
J Endovasc Ther. 2016 Jun;23(3):424-32. doi: 10.1177/1526602816641669. Epub 2016 Apr 4.
9
Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.中国南方人群经皮冠状动脉介入治疗后支架内再狭窄的发生率及危险因素。
Eur J Med Res. 2022 Jan 22;27(1):12. doi: 10.1186/s40001-022-00640-z.
10
Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.分析单核细胞/高密度脂蛋白胆固醇比值与早发冠心病患者支架内再狭窄的相关性。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221079334. doi: 10.1177/10760296221079334.

引用本文的文献

1
Predictive Scoring Model for In-Stent Restenosis Risk in Coronary Artery Disease Patients.冠心病患者支架内再狭窄风险的预测评分模型
Med Sci Monit. 2025 Jun 11;31:e947986. doi: 10.12659/MSM.947986.
2
The association of abdominal obesity with the incidence of in-stent restenosis and thrombosis.腹部肥胖与支架内再狭窄及血栓形成发生率的关联。
ARYA Atheroscler. 2025;21(2):43-50. doi: 10.48305/arya.2025.43542.3033.
3
Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation.

本文引用的文献

1
Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).血管内超声对经皮冠状动脉介入治疗支架内再狭窄(iOPEN-ISR 研究)后结局的影响。
Int J Cardiol. 2021 Oct 1;340:17-21. doi: 10.1016/j.ijcard.2021.08.003. Epub 2021 Aug 8.
2
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的入路交叉。
JACC Cardiovasc Interv. 2021 Feb 22;14(4):361-373. doi: 10.1016/j.jcin.2020.11.042.
3
Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation.
比较Gensini评分和SYNTAX评分对冠状动脉疾病及药物洗脱支架植入患者支架内再狭窄的预测价值。
Sci Rep. 2025 Jan 7;15(1):1077. doi: 10.1038/s41598-025-85191-z.
4
Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis.药物洗脱支架置入术后支架内再狭窄的危险因素及发生率:一项系统评价和Meta分析
Rev Cardiovasc Med. 2024 Dec 24;25(12):458. doi: 10.31083/j.rcm2512458. eCollection 2024 Dec.
5
Risk prediction model for in-stent restenosis following PCI: a systematic review.经皮冠状动脉介入治疗后支架内再狭窄的风险预测模型:一项系统评价
Front Cardiovasc Med. 2024 Aug 29;11:1445076. doi: 10.3389/fcvm.2024.1445076. eCollection 2024.
6
A risk score for predicting in-stent restenosis in patients with premature acute myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stent.预测接受药物洗脱支架经皮冠状动脉介入治疗的早发急性心肌梗死患者支架内再狭窄的风险评分。
Heliyon. 2024 Jul 4;10(13):e34077. doi: 10.1016/j.heliyon.2024.e34077. eCollection 2024 Jul 15.
7
Impact of exercise dosages based on American College of Sports Medicine recommendations on lipid metabolism in patients after PCI: a systematic review and meta-analysis of randomized controlled trials.基于美国运动医学学会建议的运动剂量对 PCI 后患者脂代谢的影响:随机对照试验的系统评价和荟萃分析。
Lipids Health Dis. 2024 Jul 24;23(1):226. doi: 10.1186/s12944-024-02210-0.
8
A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.经皮冠状动脉介入治疗后支架再狭窄的临床、辅助检查和遗传因素的系统评价和生物信息学研究。
BMC Cardiovasc Disord. 2024 Jun 14;24(1):304. doi: 10.1186/s12872-024-03955-3.
9
A systematic review of clinical and biomechanical engineering perspectives on the prediction of restenosis in coronary and peripheral arteries.冠状动脉和外周动脉再狭窄预测的临床与生物力学工程视角的系统综述。
JVS Vasc Sci. 2023 Sep 15;4:100128. doi: 10.1016/j.jvssci.2023.100128. eCollection 2023.
10
Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.冠心病患者冠状动脉药物洗脱支架初次植入后支架内再狭窄的风险调查
Front Cardiovasc Med. 2023 Mar 10;10:1117915. doi: 10.3389/fcvm.2023.1117915. eCollection 2023.
S100A12在预测冠状动脉药物洗脱支架植入患者支架内再狭窄中的价值。
Exp Ther Med. 2020 Jul;20(1):211-218. doi: 10.3892/etm.2020.8721. Epub 2020 May 6.
4
Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics.基于日常人口统计学、临床和血管造影特征的机器学习预测支架再狭窄。
Can J Cardiol. 2020 Oct;36(10):1624-1632. doi: 10.1016/j.cjca.2020.01.027. Epub 2020 Feb 7.
5
Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation.冠心病患者行西罗莫司洗脱支架置入术后再狭窄的发生及预测因素。
Ir J Med Sci. 2020 Aug;189(3):907-915. doi: 10.1007/s11845-020-02176-9. Epub 2020 Jan 27.
6
The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention.在接受经皮冠状动脉介入治疗的患者中,支架数量是支架再狭窄的独立危险因素。
Medicine (Baltimore). 2019 Dec;98(50):e18312. doi: 10.1097/MD.0000000000018312.
7
Mean Platelet Volume Does Not Predict Restenosis After Carotid Artery Stenting in Whites.血小板平均体积不能预测白人颈动脉支架置入术后再狭窄。
Stroke. 2020 Mar;51(3):986-989. doi: 10.1161/STROKEAHA.119.028180. Epub 2019 Dec 18.
8
European Society of Cardiology: Cardiovascular Disease Statistics 2019.欧洲心脏病学会:《2019年心血管疾病统计数据》
Eur Heart J. 2020 Jan 1;41(1):12-85. doi: 10.1093/eurheartj/ehz859.
9
Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome.CYP2C19 和 PON1 Q192R 基因型通过血栓弹力描记法影响急性冠状动脉综合征患者氯吡格雷的血小板反应。
Cardiovasc Ther. 2019 Jul 18;2019:3470145. doi: 10.1155/2019/3470145. eCollection 2019.
10
CHADS-Vasc score and CHADS-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.CHADS-Vasc评分和CHADS-Vasc-HS评分在接受冠状动脉药物洗脱支架治疗的患者中,对支架内再狭窄的预测能力较差。
J Int Med Res. 2019 Jun;47(6):2533-2544. doi: 10.1177/0300060519841836. Epub 2019 Apr 30.